Verified
Gilead Sciences
Drug Manufacturing & Research
Founded: 1987
Headquarters: 333 Lakeside Drive, Foster City, California, 94404, USA
Overview
Location
California, United States
Headquarter
333 Lakeside Drive, Foster City, California, 94404, USA
Contact Number
1-650-574-3000
No of Employees
18000
Industry
Drug Manufacturing & Research
Contact Email
public_affairs@gilead.com
Company Type
Public Company
Website
Founded
1987
CEO
Daniel O'Day
Codes
SIC Code 87,873 | NAICS Code 54,541
Annual Revenue
27.11 Billion USD
Total Funding
$296.3M
Recent Funding Amount
$210M
No of Funding Rounds
2
Founders
Michael L. Riordan
Company Overview
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, In
Employees by Level
C-Level
21
VP-Level
246
Director
5043
Manager
3825
Non-Manager
7434
Top Contacts
14312
Top C-suite Members of Company
Connect with key decision-makers at Gilead Sciences. View contact details of C-suite executives and leadership team.
| Name | Title | Contact | |
|---|---|---|---|
| Andrew Dickinson | Chief Financial Officer | a****n@gilead.com | |
| Keith Elliott | Senior Chief Marketing Officer | k****t@gilead.com | |
| Maryna Skawinska | Regional Chief Financial Officer | m****a@gilead.com | |
| Saúl Estrada | Chief Financial Officer | s****a@gilead.com | |
| Kurt Leutzinger | Executive Vice President | k****r@gilead.com | |
| Tina Franklin | Senior Director | t****n@gilead.com | |
| Anna Tuazon | Director | a****n@gilead.com | |
| Leslie Pilot-Gatton | President | l****n@gilead.com | |
| Vinessa Pearson | Head Strategy | v****n@gilead.com | |
| Bennett Luft | Chief of Staff Strategy | b****t@gilead.com | |
| Akash Patnaik | Corporate Controller | a****k@gilead.com | |
| Rashmi Ramchandani | Vice President | r****i@gilead.com | |
| Ryota Ishikawa | Financial Controller | r****a@gilead.com | |
| Lindblad Paul | Controller | l****l@gilead.com | |
| Iveth Tenorio | Controller and Finanzas | i****o@gilead.com | |
| Jyoti Mehra | Executive Vice President | j****a@gilead.com | |
| Bennett Luft | Chief of Staff Strategy | b****t@gilead.com | |
| Daniel O'Day | Chief Executive Officer | d****y@gilead.com | |
| Tina Franklin | Senior Director | t****n@gilead.com | |
| Vinessa Pearson | Head Strategy | v****n@gilead.com | |
| Anna Tuazon | Director | a****n@gilead.com |
Employees Contact
Are you Seeking to connect with decision-makers? Acquire their contact info, including emails and phone numbers, from credible sources like LinkedIn or trusted websites.
| Name | Position | Phone | Profile | |
|---|---|---|---|---|
Les Gill | Hr Shared Services | ******8400 | l.......l@gilead.com | |
Karen Hurley | R&d Staffing | ******3000 | k.......y@gilead.com | |
Tracy Duncan | Laboratory Operations Specialist Iii, Pdm Analytical Operations | *******8433 | t.......2@gmail.com | |
Jerome Roa | Senior Manager, Qa Operations | ******3968 | j.......a@baxter.com | |
Julie Di Paolo | Biology | ******9942 | j.......o@gilead.com | |
Carl Enell | Corporate Development | ******4665 | c.......l@mac.com | |
Stacey Drabic | Research Scientist | ******8653 | s.......c@gilead.com | |
Olga Minkov | Executive Director, Operations | ******1672 | o.......v@takeda.com | |
Brandon Newell | Clinical Quality Assurance | ******6200 | b.......l@gilead.com | |
Laura Hansen | Director-corporate Accounting And Reporting | ******6331 | l.......n@gmail.com | |
Michael Fong | Hiv Therapeutic Specialist | ******1847 | m.......g@gsk.com | |
Jessica Romero | Associate Director | *******4280 | j.......3@hotmail.com | |
Priyan Piyaratna | Senior Finance Project Manager | ******9333 | p.......a@gmail.com | |
Jaspal Phull | Senior Research Associate Ii | ******4244 | j.......6@gmail.com | |
Ruth Chu | Scientist Biology | ******1086 | c.......2@gmail.com | |
Alison Blaschke | Senior Manager, Alliance Management | ******4420 | a.......e@gilead.com | |
Phuong Ho | Quality Engineer Iii | ******3837 | p.......o@pearltherapeutics.com | |
Mary Forrest | Senior Administrative Assistant At Gilead Sciences | ******2562 | m.......t@gilead.com | |
Ericka Nunez | Recruiter Talent Acquisition | ******3000 | e.......z@gilead.com | |
John Magliula | Therapeutic Ischemic Heart Disease | ******3390 | j.......a@gilead.com | |
Patty Williamson | Director Clinical Contracts And Finance | ******5658 | p.......u@yahoo.com | |
Wenjun Liu | Finance Fp&a | ******7546 | w.......u@gilead.com | |
Hao Chai | Biostatistician | *******0584 | h.......i@uiowa.edu | |
Cindy Lee | Financial Systems | ******3000 | c.......e@gilead.com | |
Gregory Czerwieniec | Senior Research Scientist I | ******9333 | g.......c@gmail.com | |
Shadi Kelly | Learning Development | ******3000 | s.......y@gilead.com | |
Ryan Mckeel | Senior Director, Public Affairs | ******6705 | r.......l@hotmail.com | |
Yuming Chiu | Director, Hiv Patient And Consumer Marketing | ******7702 | y.......u@jnj.com | |
Angelina Novion | Associate Manager Commercial Qa | ******5834 | a.......n@gilead.com | |
Meera Shankar | Senior Research Associate, High Throughput Biology | ******8647 | m.......r@mgh.harvard.edu | |
Bob Panni | Medical Science Liaison | Principal Medical Scientist | Associate Director, Medical Science | ******3000 | b.......i@gilead.com | |
Greg Nichols | Service Transition | ******4087 | g.......s@gilead.com | |
Brian Plummer | Associate Director, Public Affairs | ******5207 | b.......r@gilead.com | |
Lir Tan | Associate Director, Information Management - Mdm And Data Governance | *******1974 | l.......e@hotmail.com | |
Tom Mcquaid | Medical Affairs | ******3554 | t.......d@gilead.com | |
Joseph Priore | Therapeutic Specialty Representative | ******4415 | j.......e@gilead.com | |
Lisa Daniels | Senior Therapeutic Specialist Hiv | ******5282 | l.......s@gilead.com | |
Elizabeth Etherton | Manager, Strategy And Operations | Government Affairs And Policy | ******5614 | e.......e@state.gov | |
Sean Collins | Director, Marketing | ******5068 | s.......s@abbott.com | |
Sujatha Narayan | Regulatory Affairs | ******3000 | s.......a@gilead.com | |
Jonathan Smith | Solutions Architect Site Support Services | ******3000 | j.......h@gilead.com | |
Kevin Stanek | Hr Data Analytics Intelligence | ******3000 | k.......k@gilead.com | |
Chen Chi | Associate Director | *******8400 | c.......i@gilead.com | |
Jennifer Archer | Product Launch Coordinator | ******8285 | j.......r@gilead.com | |
Michael Ischay | Research Scientist Ii And Senior Research I | *******2856 | m.......y@gilead.com | |
Terrence Dahl | Commercial Manufacturing | ******5830 | t.......l@gilead.com | |
Jose Partida | Clinical Trial Management Associate At Gilead Sciences | ******4279 | j.......a@gilead.com | |
Brian Fergason | Associate Director, Global Supply Chain | *******5874 | b.......n@bd.com | |
Leah Lessard | Therapeutic Hiv Sales | ******7308 | l.......d@gmail.com | |
Divija Kurra | Validation Engineer Iii | *******7423 | d.......a@gilead.com | |
Vikram Nimmala | Data Engineering | ******0458 | v.......a@gmail.com | |
Matthew Cook | Executive Director, Strategic Projects, Chief Executive Officer Office At Gilead Sciences | ******9333 | c.......t@bcg.com | |
Zack Finders | Application Engineer | *******7012 | z.......s@gilead.com | |
Andrew Plummer | Executive Director | ******6173 | a.......r@gmail.com | |
Stephen Chien | Senior Associate General Counsel | ******6000 | s.......n@cov.com | |
Robert Milburn | Senior Sesearch Scientist 2 | *******1238 | r.......n@amgen.com | |
Angus Hsu | Financial Hiv | *******4199 | a.......u@gilead.com | |
Tricia Espinosa | Validation Engineer | ******9260 | t.......a@gilead.com | |
James Brady | Senior Research Associate | ******8315 | j.......1@gmail.com | |
Catherine Kuo | Senior Engineer Specialist | ******3000 | c.......o@gilead.com | |
David Jordan | Senior National Account Manager At Gilead Sciences | ******5770 | d.......9@att.net | |
Jas Sohal | Senior Buyer | ******3196 | j.......l@sccoe.org | |
Oliver Cheng | Business It Operations | ******3000 | o.......g@gilead.com | |
Jim Hartke | Vice President, Nonclinical Safety And Pathobiology, Gilead Sciences | *******2070 | j.......e@sbcglobal.net | |
Darya Rose | Managed Markets Marketing | *******6744 | d.......d@gmail.com | |
Michael Rembis | Business It Operations | ******3000 | m.......s@gilead.com | |
Mike Branham | Senior Director, Clinical Qa | ******8125 | m.......m@gilead.com | |
Lisandro Grullon | Technical Manager | ******7255 | l.......n@gilead.com | |
M Orelus | Executive Assistant Int'l Government Affairs And Federal Government Affairs | ******9118 | c.......s@astrazeneca.com | |
Thomas Tarnowski | Bioanalytical Chemistry | ******9296 | t.......1@aol.com | |
Srinivas Palakodaty | Director, Manufacturing At Gilead Sciences | *******8400 | s.......y@gilead.com | |
Jim Reed | Therapeutic Oncology Specialist | ******3480 | j.......d@gilead.com | |
Lucas Man | Senior Research Associate I | ******7454 | l.......n@upenn.edu | |
Cece Smithwick | Executive Therapeutic Specialist And Regional | ******9673 | c.......k@gilead.com | |
Lindsey May | Senior Research Associate Ii | ******4000 | l.......y@ku.edu | |
Tom Mclean | Senior Director - Nash Medical Science Liaisons | ******3000 | t.......n@gilead.com | |
Stephen Han | Software Developer Research Informatics | ******7546 | s.......n@gmail.com | |
Cuichen Wu | Senior Research Scientist | *******6274 | w.......n@gmail.com | |
Nhat Phung | Business Process Analyst | ******5048 | n.......g@bhhc.com | |
Alexandru Hanganu | Drug Safety Specialist | *******9621 | h.......u@gene.com | |
Elke White | Training | ******4354 | e.......e@yahoo.com | |
Catherine Slotkoff | Executive Therapeutic | ******1090 | c.......f@gilead.com | |
Christopher Feliciano | Qa Manager At Gilead Sciences | ******8282 | d.......e@aol.com | |
Xi Huang | Senior Manager Biostatistics | *******6261 | h.......2@gmail.com | |
Joydeep Ganguly | Senior Vice President, Corporate Operations | ******7339 | j.......y@gilead.com | |
Debra Byas | Safety | ******2411 | d.......s@hotmail.com | |
Lauren Temme | Hiv Medical Affairs | *******0913 | l.......e@gilead.com | |
Beau Shelton | Laboratory Information Systems Engineer | *******9303 | b.......n@yahoo.com | |
Philip Ngo | Project | ******3000 | n.......p@hotmail.com | |
Catherine Curry | Qa Documentation | ******4218 | c.......1@gmail.com | |
Sarah Chapline | Distribution | *******8400 | s.......e@gilead.com | |
Laura Reynolds | Associate Director, Medical Affairs Operations, Process Innovation | ******8894 | l.......7@gmail.com | |
Garnet Kim | Risk Management Scientist - Pharmacovigilance And Epidemiology | ******7819 | g.......k@alumni.uci.edu | |
Linesh Sheth | Information Technology | ******3000 | s.......h@hotmail.com | |
George Nguyen | Senior Validation Engineer | ******4208 | g.......s@hotmail.com | |
Darryl Dixon | Senior Research Scientist I | ******4603 | d.......n@bms.com | |
Gokul Nair | Business Consultant | ******8474 | g.......l@hotmail.com | |
Eric Tye | Director Market Research | ******6303 | e.......7@gmail.com | |
Ona Reiter | Gmp Compliance Training | ******0480 | o.......r@gilead.com | |
Alfreda Scott | Qa, Manager | ******8222 | a.......t@gilead.com |
Email Formats
Discover the email patterns used at Gilead Sciences to connect with the right people.
The predominant email format at Gilead Sciences is first.last (e.g., jon.doe@gilead.com), utilized by 75.07% of all professional email addresses at the organization.
| Email Format | Example | Percentage |
|---|---|---|
| first.last | jon.doe@gilead.com | 75.07% |
| first initials + last | jdoe@gilead.com | 11.70% |
| first + last | jondoe@gilead.com | 7.09% |
| first_last | jon_doe@gilead.com | 3.26% |
| first | jon@gilead.com | 3.18% |
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.
Enter a person's name or an email address to verify
Technology Stack
Frequently Asked Questions
What is the address of Gilead Sciences's headquarters?
Gilead Sciences is headquartered at 333 Lakeside Drive, Foster City, California, 94404, USA.
How can I contact Gilead Sciences by phone?
You can reach Gilead Sciences by calling their customer support number at 1-650-574-3000.
Which stock symbol does Gilead Sciences trade under?
The stock ticker for Gilead Sciences is GILD.
What is the official website for Gilead Sciences?
You can visit Gilead Sciences's official website at www.gilead.com.
How much revenue does Gilead Sciences generate?
Gilead Sciences reports an annual revenue of approximately 27.11 Billion USD.
What is the SIC code for Gilead Sciences?
The Standard Industrial Classification (SIC) code for Gilead Sciences is 87,873.
What is the NAICS code for Gilead Sciences?
Gilead Sciences falls under the NAICS code 54,541.
How many people work at Gilead Sciences?
Gilead Sciences has a workforce of about 18000 employees.
Which technologies are used by Gilead Sciences?
Gilead Sciences utilizes technologies like Open Graph, FullCalendar, Google Analytics.
Who is the Chief Executive Officer (CEO) of Gilead Sciences?
The CEO of Gilead Sciences is Daniel O'Day.
How can I get in touch with Gilead Sciences?
To contact Gilead Sciences, call 1-650-574-3000 or visit their website at www.gilead.com
Is Gilead Sciences a publicly traded company?
Yes, Gilead Sciences is publicly listed and trades under the stock symbol GILD.
How much total funding has Gilead Sciences secured so far?
To date, Gilead Sciences has raised $296.3M across 2 funding round(s).
Which industry is Gilead Sciences part of?
Gilead Sciences operates in the Drug Manufacturing & Research, Pharmaceuticals, Healthcare industry.
Who are the main competitors of Gilead Sciences?
Key competitors of Gilead Sciences include Amgen, Vertex Pharmaceuticals, Biogen, Cipla
Which companies has Gilead Sciences acquired?
Acquisitions by Gilead Sciences include Cgi Pharmaceuticals, Corus Pharma, Pharmasset, Myogen .
Who holds the CFO position at Gilead Sciences?
Andrew Dickinson serves as the Chief Financial Officer (CFO) at Gilead Sciences.
When did Gilead Sciences complete its most recent funding round?
GILEAD SCIENCES latest funding round closed on Feb 28, 2024 with the amount of $210 Million
Generate quality leads for your business
Connect with anyone who has a LinkedIn URL, regardless of their
industry, department, company, or country.
Free Credits to claim
No credit card needed
Instant leads result